Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G. G. Radulesku"'
Autor:
E. G. Boichenko, E. M. Petrova, M. B. Ivanovskaya, I. A. Garbusova, M. B. Belogurova, G. G. Radulesku, Yu. V. Roumiantseva, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. I. Ponomareva, N. R. Tukalova, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 12-21 (2022)
Comparative retrospective analysis of treatment results of three different chemotherapy protocols - ALL BFM 90m, ALL MB 91 and PECO 92 — in primary ALL patients aged before 18 years, registered in Moscow and St-Petersburg clinics from 01.01.1993 to
Externí odkaz:
https://doaj.org/article/d12d41e8fa8840ca9152f851f59db814
Autor:
E. G. Boychenko, E. M. Petrova, I. A. Garbuzova, E. A. Nikitina, L. M. Shchugareva, T. N. Kulakova, T. A. Makarova, M. B. Belogurova, G. G. Radulesku, T. D. Viktorovich, E. D. Chavpetsova, L. I. Shats, G. I. Uleyskaya, I. S. Martynkevich, E. E. Zueva
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 8-17 (2014)
Treatment results in children with acute lymphoblastic leukemia (ALL) treating in St.-Petersburg hospitals according to two modified version of German protocol CO ALL-92 from 01.01.1993 to 01.01.2007 are presented. 438 primary A LL patients aged from
Externí odkaz:
https://doaj.org/article/4158a2e975004c53a05d8a212d26f912
Autor:
А. Yu. Smirnova, G. G. Radulesku, N. А. Vorobyov, I. V. Bezyazychnaya, N. I. Martynova, D. A. Morgacheva, M. B. Belogurova, Yu. V. Dinikina
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:11-26
Introduction. Central nervous system (CNS) tumors are the most common pediatric solid tumor, that need multimodality treatment approach including surgery, intensive chemotherapy (CT) and radiotherapy (RT). Due to toxicity, mostly late, RT has limited
Autor:
G G, Radulesku, B A, Kolygin
Publikováno v:
Voprosy onkologii. 30(6)
The effectiveness of a new procedure of inductive polychemotherapy (vincristine, cyclophosphamide, adriamycin and prednisolone) was studied in 60 non-pretreated cases of pediatric non-Hodgkin's lymphoma. The treatment was given in 7-day courses. Remi